Clinical Trial Update: A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the interaction between the investigational compound NNC0194-0499 and birth control pills; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• NNC0194-0499
• Oral contraceptive pills (combined oral contraceptive)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers (Non-alcoholic Steatohepatitis) | Phase 1 | Status: COMPLETED